- Report
- October 2024
- 181 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- October 2024
- 192 Pages
Global
From €3248EUR$3,545USD£2,760GBP
€3608EUR$3,939USD£3,067GBP
- Report
- April 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- April 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- May 2025
- 196 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 72 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2748EUR$3,000USD£2,336GBP
- Report
- August 2024
- 150 Pages
Global
From €2555EUR$2,789USD£2,171GBP
- Report
- June 2024
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- September 2024
- 117 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- December 2022
- 66 Pages
Global
From €2244EUR$2,450USD£1,907GBP
€3206EUR$3,500USD£2,725GBP
- Report
- August 2023
- 336 Pages
Global
From €2982EUR$3,255USD£2,534GBP
€4260EUR$4,650USD£3,620GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3298EUR$3,600USD£2,803GBP
- Report
- July 2023
- 220 Pages
Global
From €1823EUR$1,990USD£1,549GBP
- Report
- May 2024
- 140 Pages
Global
From €5953EUR$6,499USD£5,060GBP
- Report
- March 2022
- 124 Pages
Global
From €4076EUR$4,450USD£3,465GBP
- Report
- October 2020
- 133 Pages
Global
From €13736EUR$14,995USD£11,674GBP
- Report
- February 2022
- 62 Pages
Global
From €3206EUR$3,500USD£2,725GBP
- Report
- January 2024
- 120 Pages
United States
€3206EUR$3,500USD£2,725GBP
- Report
- December 2022
- 35 Pages
Global
From €1832EUR$2,000USD£1,557GBP

The Type 2 Diabetes Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat Type 2 Diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin properly. Type 2 Diabetes Drugs are used to help control blood sugar levels, reduce the risk of complications, and improve overall health. These drugs can be taken orally, injected, or inhaled. Common Type 2 Diabetes Drugs include Metformin, Sulfonylureas, Thiazolidinediones, Meglitinides, DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors.
Some companies in the Type 2 Diabetes Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, AstraZeneca, Boehringer Ingelheim, and Takeda. Show Less Read more